Article Details

Dewpoint Therapeutics launches with $60m Series A to advance proprietary platform for drugging ...

Retrieved on: 2019-01-30 15:52:30

Tags for this article:

Click the tags to see associated articles and topics

Dewpoint Therapeutics launches with $60m Series A to advance proprietary platform for drugging .... View article details on hiswai:

Excerpt

<div>Founding investor <b>Polaris Partners</b> led the equity round and was joined by Samsara BioCapital, 6 Dimensions Capital, EcoR1 Capital, Alexandria ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up